Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis

被引：0

作者：

Poynton, Edward ^{[1
,2
]}

Chernucha, Emily ^{[3
]}

Day, James ^{[2
]}

Prodger, Catherine ^{[4
]}

Hopkins, David ^{[5
]}

Rakesh, Pallav ^{[5
,6
]}

O'Neill, Tess ^{[7
]}

Thakrar, Nisha ^{[2
]}

Akarca, Ayse ^{[8
]}

Jamal, Esraa ^{[1
]}

Ali, Ayesha ^{[9
]}

Kirkwood, Amy A. ^{[10
]}

Pomplun, Sabine ^{[8
]}

Marafioti, Teresa ^{[8
]}

Calaminici, Maria

Greaves, Paul ^{[11
]}

Chaganti, Sridhar ^{[6
]}

Mckay, Pam

Smith, Jeffery ^{[12
]}

Eyre, Toby A.

Martinez-Calle, Nicolas ^{[3
]}

Cwynarski, Kate ^{[2
]}

Fox, Christopher P. ^{[13
]}

Okosun, Jessica

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England

[2] Univ Coll London Hosp, Dept Clin Haematol, London, England

[3] Nottingham Univ Hosp NHS Trust, Nottingham, England

[4] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England

[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[6] Univ Hosp Birmingham NHS Fdn Trust, Ctr Clin Haematol, Birmingham, W Midlands, England

[7] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Haemato Oncol, London, England

[8] Univ Coll London Hosp, Dept Histopathol, London, England

[9] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England

[10] UCL, Canc Res UK, London, England

[11] Barking Havering & Redbridge Univ Hosp NHS Trust, Dept Haematol, London, England

[12] Liverpool Univ Hosp, Clatterbridge Canc Ctr, Liverpool, Merseyside, England

[13] Univ Nottingham, Sch Med, Nottingham, England

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

PCNSL; primary CNS Lymphoma; double expressor; MYC; BCL2;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ABCL-184

引用

页码：S423 / S424

页数：2

共 50 条

[1] Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis
Poynton, Edward
Chernucha, Emily
Day, James
Prodger, Catherine
Hopkins, David
Rakesh, Pallav
O'Neill, Tess
Thakrar, Nisha
Akarca, Ayse
Jamal, Esraa
Ali, Ayesha
Kirkwood, Amy A.
Pomplun, Sabine
Marafioti, Teresa
Calaminici, Maria
Greaves, Paul
Chaganti, Sridhar
McKay, Pam
Smith, Jeffery
Eyre, Toby A.
Martinez-Calle, Nicolas
Cwynarski, Kate
Fox, Christopher P.
Okosun, Jessica
BLOOD ADVANCES, 2024, 8 (07) : 1772 - 1775
[2] Impact of Double Expression of MYC and BCL-2 on Outcomes in Primary CNS Lymphoma: A UK Multicentre Analysis
Poynton, Edward
Chernucha, Emily
Day, James
Prodger, Catherine
Hopkins, David
Rakesh, Pallav
O'Neill, Tess
Thakrar, Nisha
Akarca, Ayse
Pomplun, Sabine
Marafioti, Teresa
Calaminici, Maria
Chaganti, Sridhar
McKay, Pam
Smith, Jeffery
Eyre, Toby A.
Martinez-Calle, Nicolas
Cwynarski, Kate
Fox, Christopher P.
Okosun, Jessica
BLOOD, 2022, 140
[3] Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
A Kawajiri
D Maruyama
A M Maeshima
J Nomoto
S Makita
H Kitahara
K-i Miyamoto
S Fukuhara
T Suzuki
W Munakata
K Tajima
J Itami
H Taniguchi
Y Kobayashi
K Tobinai
Blood Cancer Journal, 2016, 6 : e477 - e477
[4] Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
Kawajiri, A.
Maruyama, D.
Maeshima, A. M.
Nomoto, J.
Makita, S.
Kitahara, H.
Miyamoto, K-i
Fukuhara, S.
Suzuki, T.
Munakata, W.
Tajima, K.
Itami, J.
Taniguchi, H.
Kobayashi, Y.
Tobinai, K.
BLOOD CANCER JOURNAL, 2016, 6 : e477 - e477
[5] BCL2 Expression and BCL2/MYC Dual Expression Correlates with Inferior Survival in Primary Central Nervous System Lymphoma
Uppal, G.
Wang, Z-X
Bajaj, R.
Curtis, M.
Solomides, C. C.
Glass, J.
Banks, P.
Peiper, S. C.
Gong, J. Z.
LABORATORY INVESTIGATION, 2014, 94 : 383A - 383A
[6] BCL2 Expression and BCL2/MYC Dual Expression Correlates with Inferior Survival in Primary Central Nervous System Lymphoma
Uppal, G.
Wang, Z-X
Bajaj, R.
Curtis, M.
Solomides, C. C.
Glass, J.
Banks, P.
Peiper, S. C.
Gong, J. Z.
MODERN PATHOLOGY, 2014, 27 : 383A - 383A
[7] Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
Savage, Kerry J.
Slack, Graham W.
Mottok, Anja
Sehn, Laurie H.
Villa, Diego
Kansara, Roopesh
Kridel, Robert
Steidl, Christian
Ennishi, Daisuke
Tan, King L.
Ben-Neriah, Susana
Johnson, Nathalie A.
Connors, Joseph M.
Farinha, Pedro
Scott, David W.
Gascoyne, Randy D.
BLOOD, 2016, 127 (18) : 2182 - 2188
[8] Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy
Suzuki, Tomotaka
Maruyama, Dai
Maeshima, Akiko Miyagi
Tajima, Kinuko
Ito, Yuta
Hatta, Shunsuke
Yuda, Sayako
Makita, Shinichi
Fukuhara, Suguru
Munakata, Wataru
Suzuki, Tatsuya
Taniguchi, Hirokazu
Kobayashi, Yukio
Izutsu, Koji
Tobinai, Kensei
BLOOD, 2017, 130
[9] Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-protein-expression" lymphoma with MYC and BCL2 rearrangements
Uchida, Akiko
Isobe, Yasushi
Asano, Junko
Uemura, Yu
Hoshikawa, Masahiro
Takagi, Masayuki
Miura, Ikuo
HAEMATOLOGICA, 2019, 104 (07) : 1417 - 1421
[10] Double-hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report
Zhang, Yan
Wang, Wei
Chen, Tingting
ONCOLOGY LETTERS, 2023, 25 (04)

← 1 2 3 4 5 →